Lv0
0 积分 2022-06-07 加入
Ischaemic stroke in 2024: progress on multiple fronts
19小时前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
7个月前
已完结
FDA approves an inhibitor of a novel ‘epigenetic writer’
2年前
已完结
FDA new drug approvals in Q1 2020
2年前
已完结
Complementary assets, strategic alliances, and the incumbent’s advantage: an empirical study of industry and firm effects in the biopharmaceutical industry
2年前
已完结
FDA new drug approvals in Q2 2022
2年前
已完结
Evolution of drug delivery systems: From 1950 to 2020 and beyond
2年前
已完结
Novel Reagent Space: Identifying Unorderable but Readily Synthesizable Building Blocks
2年前
已完结
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
2年前
已完结
皖公网安备34019202002308
